首页 | 本学科首页   官方微博 | 高级检索  
检索        

75例卵巢交界性上皮性肿瘤的诊治及预后分析
引用本文:沈红雁,夏咏梅,赵卫东.75例卵巢交界性上皮性肿瘤的诊治及预后分析[J].安徽医药,2012,16(7):960-962.
作者姓名:沈红雁  夏咏梅  赵卫东
作者单位:安徽医科大学,安徽,合肥,230032;安徽医科大学附属六安医院,安徽,六安,237000;安徽医科大学附属省立医院,安徽,合肥,230001
摘    要:目的探讨卵巢交界性上皮肿瘤的临床特点、诊治方法及相关预后。方法回顾性分析75例卵巢交界性上皮性肿瘤的临床资料。结果 75例患者中,平均发病年龄为(45.3±3.5)岁;病理分类为浆液性35例,黏液性39例,子宫内膜样1例;单侧72例,双侧3例;结合术后病理检查临床分期为Ⅰ期56例(其中Ⅰa期33例),Ⅱ期9例,Ⅲ期10例;患者均行手术治疗,部分患者(19例)辅助以化疗(CP或PAC方案);随访患者69例,其中复发2例,死亡1例。结论卵巢交界性上皮性肿瘤预后良好,手术是其主要的治疗方式,对于早期有生育要求的患者可选择保守性手术,力求将肿瘤完全切除,晚期患者应行根治性手术;患者术后可辅助化疗,并积极随访,可提高患者生存率。

关 键 词:卵巢  交界性肿瘤

Borderline ovarian tumor:a clinical analysis of 75 cases
SHEN Hong-yan , XIA Yong-mei , ZHAO Wei-dong.Borderline ovarian tumor:a clinical analysis of 75 cases[J].Anhui Medical and Pharmaceutical Journal,2012,16(7):960-962.
Authors:SHEN Hong-yan  XIA Yong-mei  ZHAO Wei-dong
Institution:1. Anhui Medical University, Hefei 230032, China ;2. Luan Hospital Affiliated to Anhui Medical University, Luan 237000, China; 3. The Affiliated Provincial Hospital of Anhui Medical University,Hefei 230001, China)
Abstract:Objective To explore the clinical features and management of borderline ovarian tumor (BOT). Methods Seventy-five cases with BOT were analyzed retrospectively. Results The average age of the patients was 45.3 years. Pathological type included 35 cases of serious tumor,39 cases of mucous tumor, 1 case of endometrioid tumor. 72 cases were unilateral,3 cases bilateral. All the patients accepted surgical treatment ,56 cases of which were in surgical-pathologic stage I ,9 cases stage I1,10 cases stage llI. A part of those( 19 cases) received postoperative chemotherapy. One case died among 69 cases followed up to the end. There were two cases relapsed. Conclusion BOT appears to have a favorable prognosis, and surgery is the proved only effective treatment for BOT till now. Conservative surgery is proper treatment for young patients having fertility requirements. The terminally ill should be taken radical surgery, and received postoperative chemotherapy. We should make an active following-up mechanism to improve the survival rate of patients.
Keywords:ovarian  borderline tumors
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号